Notice2023-27405
Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 14, 2023
Issuing agencies
Environmental Protection Agency
Abstract
In the Federal Register of October 27, 2023, EPA announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans. This document extends the comment period, which was scheduled to end on December 26, 2023, for 60 days.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 239 (Thursday, December 14, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 239 (Thursday, December 14, 2023)]
[Notices]
[Page 86644]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-27405]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2023-0474; FRL-11384-02-OCSPP]
Endocrine Disruptor Screening Program (EDSP); Near-Term
Strategies for Implementation; Notice of Availability and Request for
Comment; Extension of Comment Period
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: In the Federal Register of October 27, 2023, EPA announced the
availability of and solicited comment on near-term strategies to help
the Agency meet its obligations and commitments under the Federal Food,
Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and
protect against endocrine disrupting effects in humans. This document
extends the comment period, which was scheduled to end on December 26,
2023, for 60 days.
DATES: The comment period for the document published in the Federal
Register of October 27, 2023, at 88 FR 73841 (FRL-11384-01-OCSPP) is
extended. Comments must be received on or before February 26, 2023.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2023-0474, through the Federal eRulemaking
Portal at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. Additional
instructions on commenting and visiting the docket, along with more
information about dockets generally, is available at <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
FOR FURTHER INFORMATION CONTACT: Catherine Aubee, Endocrine Disruptor
Screening Program (7505T), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (202) 566-1030; email address:
<a href="/cdn-cgi/l/email-protection#02726771766b616b666773776771766b6d6c71426772632c656d74"><span class="__cf_email__" data-cfemail="19697c6a6d707a707d7c686c7c6a6d7076776a597c6978377e766f">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
To give stakeholders additional time to review materials and
prepare comments, EPA is hereby extending the comment period
established in the Federal Register document of October 27, 2023, at 88
FR 73841 (FRL-11884-01-OCSPP) for 60 days, from December 26, 2023, to
February 26, 2023. More information on the action can be found in the
Federal Register of October 27, 2023.
To submit comments or access the docket, please follow the detailed
instructions provided under ADDRESSES. If you have questions, consult
the technical person listed under FOR FURTHER INFORMATION CONTACT.
(Authority: 7 U.S.C. 136 et seq. and 21 U.S.C. 346a)
Dated: December 6, 2023.
Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2023-27405 Filed 12-13-23; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 14, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.